As FDA ignores pressure from appropriators on DQSA . . .

Lawmakers Push FDA To Withdraw Guidance On Compounding, Issue Rule Allowing Practice

/ May 24, 2017 at 3:22 PM
A bipartisan coalition of 65 lawmakers is demanding FDA rescind a controversial guidance prohibiting pharmacies overseen by states from compounding without, or in anticipation of, an individual prescription, and instead issue a proposed rule allowing office-use compounding where authorized by state law. The push from lawmakers came the same day the agency ignored calls from appropriators for FDA to issue guidance allowing office-use compounding. While both groups of lawmakers allege FDA is acting against congressional intent, the agency appears to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.